Innovex International, Inc. Reports 5M-Share Selling-Stockholder Offering

What Happened
Innovex International, Inc. (INVX) filed an 8-K on August 10, 2026, reporting that certain affiliates of Amberjack Capital Partners, L.P. (the Selling Stockholders) sold 5,000,000 shares of the company’s common stock in an offering underwritten by Barclays Capital Inc. The Underwriting Agreement was entered into on August 6, 2026, the offering price to the underwriter was $28.71 per share, and the offering closed on August 10, 2026. The company did not sell any new shares in this transaction and received no proceeds.

Key Details

• Offering size: 5,000,000 shares of common stock.
• Price to underwriter: $28.71 per share.
• Parties: Selling Stockholders (affiliates of Amberjack Capital Partners, L.P.) and Barclays Capital Inc. as underwriter.
• Registration: Offered under Innovex’s shelf registration on Form S-3 (File No. 333-282178); preliminary prospectus supplement filed Aug 6, 2026 and final prospectus supplement filed Aug 10, 2026.
• Legal terms: Underwriting Agreement contains customary reps, closing conditions and indemnification obligations; a copy is filed as Exhibit 1.1.

Why It Matters
This was a secondary sale by existing shareholders, not a primary issuance — Innovex did not issue new shares and did not receive any proceeds. For investors, that means the company’s cash position and shares outstanding were not changed by this offering; however, the transaction did transfer a large block of shares into the market. The filing documents the underwriting terms and legal protections for the underwriter, which are routine for this type of transaction.